Home/finance/Rapport Therapeutics CFO Troy Ignelzi buys $143,550 in company stock By Investing.com - Investing.com Australia
Rapport Therapeutics CFO Troy Ignelzi buys $143,550 in company stock By Investing.com - Investing.com Australia
10/21/2026, 10:24:03 PM
EXECUTIVE SUMMARY
Rapport Therapeutics CFO Troy Ignelzi buys $143,550 in company stock By Investing.com Investing.com Australia
Key Takeaways
- Rapport Therapeutics CFO Troy Ignelzi buys $143,550 in company stock By Investing.com - Investing.com Australia.
Rapport Therapeutics CFO Troy Ignelzi buys $143,550 in company stock By Investing.com Investing.com Australia
Read Complete Original Article
Published originally on Google News - Stock Market
Related News
finance13 minutes ago
Nanalysis Scientific at ld micro event: growth, debt cut and scale
Nanalysis Scientific at ld micro event: growth, debt cut and scale....
finance17 minutes ago
Australia’s Santos trims 2026 output forecast on Alaska oilfield delays
Australia’s Santos trims 2026 output forecast on Alaska oilfield delays....
finance22 minutes ago
Brookings Proposes Overhaul That Could Shrink Fed's $6.8 Trillion Balance Sheet to Around $4.5 Trillion - BigGo Finance
Brookings Proposes Overhaul That Could Shrink Fed's $6.8 Trillion Balance Sheet to Around $4.5 Trillion BigGo Finance
finance26 minutes ago
FB financial director Orrin H. Ingram II buys $1.5m in stock - Investing.com Australia
FB financial director Orrin H. Ingram II buys $1.5m in stock Investing.com Australia
Multikhabar App
All Information In One Place
Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!